IXHL News and Press, Incannex Healthcare Limited From 01/15/26

MELBOURNE, Australia and NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the  Research and Development Award in the Respi...

MELBOURNE, Australia and NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, provides a 2025 corporate year-in-review and outlook for 2026, highlighting substantial clinical, r...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) fell 38.3% to $0.034 on volume of 394,331,331 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.2% to $3.02 on volume of 321,190,050 shares Virax Biolabs Group Limited (VRAX)...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) fell 39.9% to $0.0331 on volume of 320,255,883 shares Virax Biolabs Group Limited (VRAX) rose 62.9% to $0.6401 on volume of 284,826,214 shares Direxion Daily Semiconductor Bear 3X Shares (S...

MELBOURNE, Australia and NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for I...

Dallas, Texas--(Newsfile Corp. - November 20, 2025) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). In 4Q25, Incannex continued to build the clinical and patient-reported evidence base for IHL-42X in obstruct...

GRI Bio Inc. (GRI) is expected to report $-1.11 for Q3 2025 Meridian Mining UK Societas (MRRDF) is expected to report $-0.01 for Q3 2025 CaliberCos Inc. (CWD) is expected to report $-0.32 for Q3 2025 BioCorRx Inc (BICX) is expected to report $-0.06 for Q3 2025 Beneficient (BENF) i...

A look at the top 10 most actives in the United States Intensity Therapeutics Inc. (INTS) rose 173.4% to $0.7297 on volume of 385,641,574 shares Cambium Networks Corporation (CMBM) rose 88.1% to $5.55 on volume of 100,908,607 shares Harvard Bioscience Inc. (HBIO) rose 23.1% to $0.5498 on vo...

MELBOURNE, Australia and NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL)(“Incannex” or the “Company”), a clinical-stage pharmaceutical company developing innovative combination therapies for high-impact medical conditions, provides a...

2025-10-22 08:37:59 ET More on Incannex Healthcare Incannex drops despite mid-stage trial win for lead asset in sleep apnoea Historical earnings data for Incannex Healthcare Financial information for Incannex Healthcare Read the full article on Seeking Alph...